Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies

Javeed Iqbal(University of Nebraska Medical Center), WC Chan(University of Nebraska Medical Center), Huimin Geng(University of California, San Francisco), Ivy F.L. Tsui, David Klinkebiel(University of Nebraska Medical Center), Kajia Cao(University of Nebraska at Omaha), Norio Shimizu(Tokyo Medical and Dental University), Hesham Ali(Mansoura University), Ronald J. deLeeuw(BC Cancer Agency), Liangliang Shen(Shanghai University), W Tam(Cornell University), Judith K. Christman(University of Nebraska Medical Center), W.Y. Au(University of Hong Kong), Gopesh Srivastava(Chinese University of Hong Kong), Karen Dybkær(Aalborg University Hospital), Kavita Patel(Baylor College of Medicine), Wan L. Lam(University of British Columbia)
Leukemia
February 5, 2009
10.1038/leu.2009.3
Cited by 197

Related Papers

Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
|New England Journal of Medicine|2010|1.3k
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
|Journal of Clinical Oncology|2012|971
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Polyglutamine-Expanded Androgen Receptors Form Aggregates That Sequester Heat Shock Proteins, Proteasome Components and SRC-1, and Are Suppressed by the HDJ-2 Chaperone
|Human Molecular Genetics|1999|448